Document is current
Any future updates will be listed below
-
Authors
Gomez, Elisa V.
Bishop, Jessie L.
Jackson, Kimberley
Muram, Talia M.
Phillips, Diane https://orcid.org/0000-0001-7299-1075
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct02543918 at ClinicalTrials.govDocuments that mention this clinical trial
Response to Tetanus and Pneumococcal Vaccination Following Administration of Ixekizumab in Healthy Participants
https://doi.org/10.1007/s40259-017-0249-y
-
Funding
Funding for this research was provided by:
Eli Lilly and Company
- License Information
-
More Information
Article History
First Online: 7 November 2017
Compliance with Ethical Standards
: The study was conducted in accordance with consensus ethics principles derived from international ethics guidelines, including the Declaration of Helsinki and Council for International Organizations of Medical Sciences (CIOMS) International Ethical Guidelines, the International Conference on Harmonization (ICH) GCP Guideline, and applicable laws and regulations. The study protocol and informed consent forms were approved by an investigational review board, and all patients signed informed consent before undergoing study-related procedures. This article does not contain any studies with animals performed by any of the authors.
: The study was funded by Eli Lilly and Company.
: The authors are employees and stockholders of Eli Lilly and Company.
